MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

15 May 2026 Evaluate
The sales slipped to Rs. 5.78 millions, down -57.25% for the March 2026 quarter as against Rs. 13.52 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -3.59 millions as compared to Net Profit of Rs. 11.78 millions of corresponding quarter ended March 2025Operating profit Margin for the quarter ended March 2026 slipped to -3.59% as compared to 11.78% of corresponding quarter ended March 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5.78 13.52 -57.25 25.58 8.38 205.25 25.58 8.38 205.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -3.59 11.78 -130.48 9.57 -2.93 -426.62 9.57 -2.93 -426.62
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -3.59 11.78 -130.48 9.57 -2.93 -426.62 9.57 -2.93 -426.62
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -3.59 11.78 -130.48 9.57 -2.93 -426.62 9.57 -2.93 -426.62
TAX 0.00 0.00 0.00 0.97 0.00 0.00 0.97 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.59 11.78 -130.48 8.60 -2.93 -393.52 8.60 -2.93 -393.52
Equity 902.60 652.60 38.31 902.60 652.60 38.31 902.60 652.60 38.31
PBIDTM(%) -62.11 87.13 -171.28 37.41 -34.96 -207.00 37.41 -34.96 -207.00
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..